aid: enlaza-therapeutics
name: Enlaza Therapeutics
description: Enlaza Therapeutics is a clinical-stage biopharmaceutical company in La Jolla,
  California developing first-in-class covalent protein biologics for cancer and other serious
  diseases. Its proprietary War-Lock technology uses engineered unnatural amino acids to enable
  protein drugs — including antibody-drug conjugates and T-cell engagers — to bind their disease
  targets irreversibly, aiming for sustained target occupancy and a prolonged biologic effect with
  minimal systemic exposure across oncology and immuno-oncology applications. The company was
  surfaced as a portfolio company of Lightspeed Venture Partners and added to the API Evangelist
  network; it publishes a corporate website but no public developer API surface.
url: https://raw.githubusercontent.com/api-evangelist/enlaza-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://enlazatx.com/wp-content/uploads/2022/12/Enlaza_logo.svg
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Therapeutics
- Oncology
- Biologics
- Drug Discovery
- Life Sciences
apis: []
common:
- type: DomainSecurity
  url: security/enlaza-therapeutics-domain-security.yml
- type: Website
  url: https://www.enlazatx.com
- type: PrivacyPolicy
  url: http://enlazatx.com/wp-content/uploads/2022/12/Enlaza_Therapeutics_Privacy_Policy.pdf
- type: TermsOfService
  url: http://enlazatx.com/wp-content/uploads/2022/12/Enlaza_Therapeutics_Terms_of_Use_Website.pdf
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence